Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Navin Fluorine International Ltd (NAVINFLUOR) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Specialty ChemicalsManufacture and sale of diverse specialty fluorochemicals for agro and pharma sectorsTechnological expertise with in-house R&D, strategic partnerships, backward integrationB2B; global pharma and agrochemical corporationsCustom fluorochemical intermediates and new differentiated products84841Product sales to global customers including Fortune 500 companiesContract and spot sales based on volume and long-term agreementsRobust product pipeline, operationalisation of Dahej facilities, new molecule launchesFluoro-based agrochemical intermediates, specialty pharma intermediates
High Performance Products (HPP)Production of advanced refrigerants and materials for cooling systems and specialty usesProprietary technology through JV with Honeywell, early mover advantage in HFO refrigerantsB2B; automotive, HVAC manufacturers, and industrial clients globallyEco-friendly refrigerants with patented chemistry and customer certifications95546Sales contracts, volume shipments to automotive and industrial sectorsLong-term supply agreements with leading innovatorsGrowing demand for low Global Warming Potential refrigerants, new plant commissioningHFO-1234yf refrigerants, HFC gases including R32
Contract Development and Manufacturing Organization (CDMO)Contract research, development, and manufacturing services for pharma and biotech companiesSpecialized cGMP capabilities, strong regulatory compliance, customer intimacy and innovationB2B; pharmaceutical innovators primarily in Europe and USALate-stage commercial manufacturing projects26613Service contracts, milestone payments, manufacturing feesProject-based and recurring contractsStrong client partnerships, new multi-year contracts, capacity expansionsCustom fluorinated pharmaceutical intermediates

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions